Common Contracts
2 similar Subscription Agreement contracts by WaferGen Bio-Systems, Inc.
SUBSCRIPTION AGREEMENTSubscription Agreement • March 2nd, 2010 • WaferGen Bio-Systems, Inc. • Laboratory analytical instruments • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth in the signature page attached hereto (the “Subscriber”) in connection with the private placement offering (the “Offering”) of a minimum of 2,666,667 and a maximum of 5,333,334 units of securities (the “PPO Units”) issued by WaferGen Bio-systems, Inc., a Nevada Corporation (the “Company”), at a purchase price of $1.50 per PPO Unit. Each PPO Unit consists of (i) one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) a warrant, substantially in the form of Exhibit D to the Memorandum (as defined below) (the “Warrants”), representing the right to purchase 25% of one share of Common Stock, exercisable for a period of five years at an exercise price of $2.50 per whole share; and in the event the Offering is oversubscribed, the Company may, in its discretion, sell up to 1,333,333 additional Units at the same purchase price per Unit. This subscription is being s
SUBSCRIPTION AGREEMENTSubscription Agreement • August 14th, 2009 • WaferGen Bio-Systems, Inc. • Laboratory analytical instruments • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth in the signature page attached hereto (the “Subscriber”) in connection with the private placement offering (the “Offering”) of a minimum of 3,200,000 and a maximum of 6,400,000 units of securities (the “PPO Units”) issued by WaferGen Bio-systems, Inc., a Nevada Corporation (the “Company”), at a purchase price of $1.25 per PPO Unit. Each PPO Unit consists of (i) one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) a warrant, substantially in the form of Exhibit D to the Memorandum (as defined below) (the “Warrants”), representing the right to purchase 30% of one share of Common Stock, exercisable for a period of five years at an exercise price of $2.00 per whole share; and in the event the Offering is oversubscribed, the Company may, in its discretion, sell up to 1,600,000 additional Units at the same purchase price per Unit. This subscription is being s
